{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:15:55Z","timestamp":1790180155894,"version":"4.1.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>SLC35A2-CDG is a rare type of X-linked CDG with more than 60 reported cases. We retrospectively analyzed clinical phenotypes and <jats:italic>SLC35A2<\/jats:italic> genotypes of four cases of SLC35A2-CDG from four unrelated families of Han ethnicity in China. All patients had infantile onset epilepsies that were completely or partly resistant to multiple anti-epileptic medications or ketogenic diet. Three patients had severe developmental delay. All patients were female patients carrying <jats:italic>de novo<\/jats:italic> deleterious mutations in <jats:italic>SLC35A2<\/jats:italic> (NM_001042498.2) gene, including one canonical splice-site mutation (c.426+1G &amp;gt; A), one large deletion (c.-322_c.274+1del), and two frameshift mutations leading to premature stop codon (c.781delC\/p.Arg289ValfsTer88 and c.601delG\/p.Ala201GlnfsTer148). Novel clinical features in some of our patients include anemia, hypertriglyceridemia, hypertonia, small ears, extra folds on earlobes, and maternal oligohydramnios or hypothyroidism during pregnancy. In one patient, concomitant Marfan syndrome was confirmed for having positive family history, carrying a heterozygous known disease-causing mutation in FBN1 gene (c.7240C &amp;gt; T\/p.Arg2414Ter), and presence of typical features (rachnodactyly, ventrical septal defect, and mitral valve regurgitation). In conclusion, we expanded clinical phenotype and genetic mutation spectrum of SLC35A2-CDG by reporting four new cases with novel pathogenic variants and novel clinical features.<\/jats:p>","DOI":"10.3389\/fgene.2021.658786","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T16:32:30Z","timestamp":1622133150000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Four New Cases of SLC35A2-CDG With Novel Mutations and Clinical Features"],"prefix":"10.3389","volume":"12","author":[{"given":"Kuerbanjiang","family":"Abuduxikuer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-She","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s13353-018-0444-7","article-title":"Splicing mutations in human genetic disorders: examples, detection, and confirmation.","volume":"59","author":"Anna","year":"2018","journal-title":"J. Appl. Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/ejhg.2015.186","article-title":"Novel genetic causes for cerebral visual impairment.","volume":"24","author":"Bosch","year":"2016","journal-title":"Eur. J. Hum. Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"16283","DOI":"10.1016\/s0021-9258(18)37590-2","article-title":"A polarized epithelial cell mutant deficient in translocation of UDP-galactose into the Golgi complex.","volume":"263","author":"Br\u00e4ndli","year":"1988","journal-title":"J. Biol. Chem."},{"key":"B4","doi-asserted-by":"crossref","first-page":"477","DOI":"10.21037\/atm.2018.10.45","article-title":"Congenital disorders of glycosylation.","volume":"6","author":"Chang","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s10545-015-9828-6","article-title":"A new case of UDP-galactose transporter deficiency (SLC35A2-CDG): molecular basis, clinical phenotype, and therapeutic approach.","volume":"38","author":"D\u00f6rre","year":"2015","journal-title":"J Inherit Metab Dis."},{"key":"B6","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ajhg.2014.08.013","article-title":"De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies.","volume":"95","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ymgme.2017.06.014","article-title":"Impact of clinical exomes in neurodevelopmental and neurometabolic disorders.","volume":"121","author":"Evers","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"B8","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1186\/gb-2012-13-2-r9","article-title":"Predicting the effects of frameshifting indels.","volume":"13","author":"Hu","year":"2012","journal-title":"Genome Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1093\/oxfordjournals.jbchem.a021523","article-title":"Molecular cloning and characterization of a novel isoform of the human UDP-galactose transporter, and of related complementary DNAs belonging to the nucleotide-sugar transporter gene family.","volume":"120","author":"Ishida","year":"1996","journal-title":"J. Biochem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/oxfordjournals.jbchem.a022556","article-title":"Indispensability of transmembrane domains of Golgi UDP-galactose transporter as revealed by analysis of genetic defects in UDP-galactose transporter-deficient murine had-1 mutant cell lines and construction of deletion mutants.","volume":"126","author":"Ishida","year":"1999","journal-title":"J. Biochem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.braindev.2016.09.009","article-title":"A case of early onset epileptic encephalopathy with de novo mutation in SLC35A2: clinical features and treatment for epilepsy.","volume":"39","author":"Kimizu","year":"2017","journal-title":"Brain Dev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1002\/humu.22446","article-title":"De novo mutations in SLC35A2 encoding a UDP-galactose transporter cause early-onset epileptic encephalopathy.","volume":"34","author":"Kodera","year":"2013","journal-title":"Hum. Mutat."},{"key":"B13","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/glycob\/cwz016","article-title":"Functional analyses of the UDP-galactose transporter SLC35A2 using the binding of bacterial Shiga toxins as a novel activity assay.","volume":"29","author":"Li","year":"2019","journal-title":"Glycobiology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jmg.2009.072785","article-title":"The revised Ghent nosology for the Marfan syndrome.","volume":"47","author":"Loeys","year":"2010","journal-title":"J. Med. Genet."},{"key":"B15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/jmedgenet-2015-103568","article-title":"Identification of novel genetic causes of Rett syndrome-like phenotypes.","volume":"53","author":"Lopes","year":"2016","journal-title":"J. Med. Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s10719-011-9348-z","article-title":"Comparative analysis of involvement of UGT1 and UGT2 splice variants of UDP-galactose transporter in glycosylation of macromolecules in MDCK and CHO cell lines.","volume":"28","author":"Maszczak-Seneczko","year":"2011","journal-title":"Glycoconj J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/oxfordjournals.jbchem.a021404","article-title":"Human UDP-galactose translocator: molecular cloning of a complementary DNA that complements the genetic defect of a mutant cell line deficient in UDP-galactose translocator.","volume":"120","author":"Miura","year":"1996","journal-title":"J. Biochem."},{"key":"B18","doi-asserted-by":"crossref","first-page":"e814","DOI":"10.1002\/mgg3.814","article-title":"A case of de novo splice site variant in SLC35A2 showing developmental delays, spastic paraplegia, and delayed myelination.","volume":"7","author":"Miyamoto","year":"2019","journal-title":"Mol. Genet. Genomic Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.tig.2018.03.002","article-title":"Perspectives on glycosylation and its congenital disorders.","volume":"34","author":"Ng","year":"2018","journal-title":"Trends Genet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.ajhg.2013.03.012","article-title":"University of Washington Center for Mendelian Genomics, Freeze HH. Mosaicism of the UDP-galactose transporter SLC35A2 causes a congenital disorder of glycosylation.","volume":"92","author":"Ng","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"B21","first-page":"908","article-title":"SLC35A2-CDG: functional characterization, expanded molecular, clinical, and biochemical phenotypes of 30 unreported Individuals.","volume":"40","author":"Ng","year":"2019","journal-title":"Hum. Mutat."},{"key":"B22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/jhg.2016.23","article-title":"IntSplice: prediction of the splicing consequences of intronic single-nucleotide variations in the human genome.","volume":"61","author":"Shibata","year":"2016","journal-title":"J. Hum. Genet."},{"key":"B24","year":"2016"},{"key":"B25","first-page":"302","article-title":"Clinical characteristics analysis of a child with West syndrome caused by SLC35A2 gene mutation in a Marfan syndrome family and literature review.","volume":"38","author":"Tian","year":"2020","journal-title":"J. Clin. Pediatr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/jimd.12055","article-title":"Clinical, neuroradiological, and biochemical features of SLC35A2-CDG patients.","volume":"42","author":"Vals","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"B27","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12881-018-0617-6","article-title":"Mosaicism of the UDP-Galactose transporter SLC35A2 in a female causing a congenital disorder of glycosylation: a case report.","volume":"19","author":"Westenfield","year":"2018","journal-title":"BMC Med. Genet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/s41436-020-0767-8","article-title":"Clinical and biochemical improvement with galactose supplementation in SLC35A2-CDG.","volume":"22","author":"Witters","year":"2020","journal-title":"Genet. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.ejpn.2018.08.002","article-title":"SLC35A2-related congenital disorder of glycosylation: defining the phenotype.","volume":"22","author":"Yates","year":"2018","journal-title":"Eur. J. Paediatr. Neurol."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.658786\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T16:32:40Z","timestamp":1622133160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.658786\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,27]]},"references-count":29,"alternative-id":["10.3389\/fgene.2021.658786"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2021.658786","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,27]]},"article-number":"658786"}}